Brenda J Guyer

Summary

Affiliation: International Diabetes Center
Country: USA

Publications

  1. ncbi request reprint Mast cell inhibitor R112 is well tolerated and affects prostaglandin D2 but not other mediators, symptoms, or nasal volumes in a nasal challenge model of allergic rhinitis
    Brenda J Guyer
    Department of Medicine, National Jewish Medical and Research Center, Denver, Colorado, USA
    Allergy Asthma Proc 27:208-13. 2006

Collaborators

Detail Information

Publications1

  1. ncbi request reprint Mast cell inhibitor R112 is well tolerated and affects prostaglandin D2 but not other mediators, symptoms, or nasal volumes in a nasal challenge model of allergic rhinitis
    Brenda J Guyer
    Department of Medicine, National Jewish Medical and Research Center, Denver, Colorado, USA
    Allergy Asthma Proc 27:208-13. 2006
    ..Single-dose R112 appears safe and significantly reduces PGD2 but not histamine or tryptase release in response to allergen challenge in subjects with AR...